Moteur de recherche d’entreprises européennes
Financement de l’UE (3 999 873 €) : PanCareFollowUp : De nouveaux soins de survie centrés sur le patient pour améliorer la qualité, l’efficacité, la rentabilité et l’accessibilité des soins pour les … Hor01/01/2019 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
PanCareFollowUp : De nouveaux soins de survie centrés sur le patient pour améliorer la qualité, l’efficacité, la rentabilité et l’accessibilité des soins pour les survivants et les soignants
The 5-year survival for children with cancer increased from 30% in the 1970s to more than 80% at present. There are up to 300,000 childhood cancer survivors in Europe and this number is increasing. Years after treatment, childhood cancer survivors are at high risk for developing health and psychosocial late effects, resulting in excess morbidity and mortality compared the general population. The impact on the quality of life (QoL) of survivors and their families, as well as the societal and economic burdens, are significant. However, these impacts can be reduced by long-term survivorship care to detect treatable disease at an early phase and start timely interventions to preserve health, improve QoL, as well as coordinate specialised care and empower survivors. Implementing follow-up care, especially for young adult and adult survivors of childhood cancer, has proven challenging across Europe. These survivors have left paediatric care and most of them have no opportunity to visit experts in survivorship care. To improve survivorship care for these survivors across Europe, PanCareFollowUp will conduct a prospective cohort study to assess effectiveness, value, cost effectiveness and feasibility of the PanCareFollowUp Care intervention, a person-centred approach to survivor follow-up care based on international clinical guidelines for surveillance of late effects. PanCareFollowUp also includes the development and assessment of a personalised, guideline-based eHealth lifestyle intervention. Ensuring that the PanCareFollowUp interventions are used in the real world is paramount to achieving enduring improvements to survivorship care. Hence, the project includes the development of materials to support sustainable maintenance and replication of the PanCareFollowUp interventions. The PanCare network will become the guardian of the interventions after the project, ensuring that the intervention materials are openly available, sustainably maintained and widely shared.
| CHILDHOOD CANCER INTERNATIONAL | 80 417 € |
| Fakultni Nemocnice U SV Anny V Brne | 363 000 € |
| Istituto Giannina Gaslini | 451 000 € |
| Katholieke Universiteit Leuven | 400 000 € |
| Kraeftens Bekaempelse | 335 000 € |
| Lunds Universitet | 508 999 € |
| Osterreichische Kinder-Krebs-Hilfe-Verband DER Osterreichischen Kinder-Krebs-Hilfe-Organisationen Verein | 29 583 € |
| PANCARE | 62 500 € |
| Pintail Ltd. | 205 000 € |
| PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE B.V. | 711 875 € |
| Siop Europe | 117 500 € |
| STICHTING NEDERLANDS INSTITUUT VOOR ONDERZOEK VAN DE GEZONDHEIDSZORG | 120 000 € |
| STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM | 176 546 € |
| STICHTING RADBOUD UNIVERSITEIT | 133 454 € |
| UNIVERSITAT LUZERN | 220 000 € |
| University of Newcastle Upon Tyne | 84 999 € |
https://cordis.europa.eu/project/id/824982
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.